The broader flu vaccination programme will also be improved by offering eligible adults under 65, including pregnant women and those with long term health conditions, a "quadrivalent" vaccine in injected form, which protects against two strains of flu A and two strains of flu B.
"We fully acknowledge that the flu vaccine is not as effective as many of our other vaccines", said the medical examiner. "It is also critical for health care workers and people taking care of high-risk persons to be immunized".
Even if you don't get a flu shot by the end of October, experts say it's never too late to get one at any point during flu season.
The 2017-2018 season was dominated by influenza strain H3N2, which typically results in a more severe season. Is it already time to get the flu vaccine?
Investigators in this study wanted to ascertain the extent to which gender itself-not just cultural and behavioral norms around gender- could affect the effectiveness of the flu vaccine. No, not fall: Flu season.
People develop antibodies against the flu about two weeks after vaccination, so they should receive a flu shot before the virus starts spreading through their community, according to the agency.
Fact #6 - The flu changes every year. Men are more likely than women to say they're planning on getting the shot (49% vs 44%) or have already gotten the shot (6% vs 4%). Getting the vaccine if you are eligible and practising good hand hygiene is the best way to prevent yourself from getting flu.
"The authors wrote that "...these findings suggest that biological gender differences in response to the vaccine, rather than gender differences in health care seeking or vaccination status reporting, likely explains the observed differences in influenza VE between males and females". The vaccine is offered through local Global Positioning System and pharmacies.
Credit: Air Force District of Washington. Especially important given the complications from flu that older adults are susceptible to. According to corresponding author Danuta Skowronski MD, FRCPC, of the British Columbia Centre for Disease Control, if the findings are confirmed, one day physicians and vaccine developers might consider gender when developing newer influenza vaccines and flu prevention strategies. This comes from recommendations from the World Health Organization. AREG is an Epidermal Growth Factor (EGF)-like molecule that plays a critical role in wound and tissue healing following infection or injury.
Dr. Katherine O'Brien, who was awarded the Canada 150 Research Chair in Vaccinology and Global Health at Dalhousie University and is to begin work at the university on December 1, said the complexity of influenza strains makes matching vaccinations hard.